Exposure of cardiac fibroblasts to the herbicide nitrofen causes altered interactions with the extracellular matrix.
A large proportion of congenital heart defects result from dysmorphogenesis of valvuloseptal precursors, the endocardial cushions. Intrinsic to formation and maturation of these tissues are developmental changes in cell-cell and cell-extracellular matrix interactions. Interactions between cells and the extracellular matrix play critical roles in modulating cellular processes including proliferation, migration, differentiation and even survival. While significant progress is being made in the elucidation of the cellular events involved in valvuloseptal development, little is known regarding how environmental factors may affect this process. Embryonic exposure to the herbicide nitrofen has been shown to result in congenital heart defects associated with altered endocardial cushion formation or maturation. The present studies were performed to begin to address the cellular mechanisms of these nitrofen-induced effects. Heart fibroblasts were isolated and treated with varying doses of nitrofen in vitro. Experiments were performed to determine the effects of this herbicide on important cellular processes including migration, proliferation and apoptosis. These studies illustrated a dose-dependent decrease in collagen gel contraction and proliferation in response to nitrofen. Assays were also performed to determine the effects of nitrofen on fibroblast gene expression. Increased expression of collagen type I and specific integrins were seen following nitrofen exposure. These studies illustrate that nitrofen has direct effects on cardiac fibroblast proliferation and extracellular matrix remodeling, cellular events important in valvuloseptal development.
Borck
A
A
Department of Cell and Development Biology and Anatony, University of South Carolina, School of Medicine, Columbia, SC 29208, USA.
Massey
E
E
Loftis
M J
MJ
Carver
W
W
D000818:Animals; D000831:Animals, Newborn; D017209:Apoptosis; D015152:Blotting, Northern; D015153:Blotting, Western; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D002448:Cell Adhesion; D002454:Cell Differentiation; D002455:Cell Division; D002465:Cell Movement; D002470:Cell Survival; D003094:Collagen / Q000378:metabolism; D024042:Collagen Type I / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005109:Extracellular Matrix / Q000187:drug effects* / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D005786:Gene Expression Regulation; D006321:Heart / Q000187:drug effects*; D006540:Herbicides / Q000633:toxicity*; D016023:Integrins / Q000378:metabolism; D009206:Myocardium / Q000473:pathology*; D010647:Phenyl Ethers / Q000633:toxicity*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D015398:Signal Transduction
D024042:Collagen Type I; D006540:Herbicides; D016023:Integrins; D010647:Phenyl Ethers; D012333:RNA, Messenger; D003094:Collagen; C505410:Casp3 protein, rat; D053148:Caspase 3; D020169:Caspases; C007350:nitrofen